---
title: "GTBP Q1'26 Earnings: EPS estimate is (0.08) USD"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/286552803.md"
description: "GTBP (GT Biopharma, Inc.) is set to announce its Q1'26 results on May 18, time not specified. The earnings are expected to be disclosed at 8:00 AM ET (12:00 PM UTC).For Q1'26, revenue estimate is 0 USD with EPS (earnings per share) anticipated at (0.08) USD. Learn more details at .Revenue & EPS values are provided in USDQ1'25Q2'25Q3'25Q4'25Q1'26Revenue Reported—————Revenue Estimate—————Revenue SurpriseEPS Reported(0.33)(0.55)(0.83)(2.22) EPS Estimate(0.33)(0.68)(0.38)(0.22)(0.08) EPS Surprise+0.00%+19.12%-118.42%-909.09%DisclaimerSelect reference data provided by FactSet. Copyright © 2026 FactSet Research Systems Inc."
datetime: "2026-05-15T11:00:03.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/286552803.md)
  - [en](https://longbridge.com/en/news/286552803.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/286552803.md)
---

# GTBP Q1'26 Earnings: EPS estimate is (0.08) USD

GTBP (GT Biopharma, Inc.) is set to announce its Q1'26 results on May 18, time not specified. The earnings are expected to be disclosed at 8:00 AM ET (12:00 PM UTC).

For Q1'26, revenue estimate is 0 USD with EPS (earnings per share) anticipated at (0.08) USD. Learn more details at .

**Revenue & EPS values are provided in USD**

Q1'25

Q2'25

Q3'25

Q4'25

Q1'26

**Revenue Reported**

—

—

—

—

—

**Revenue Estimate**

—

—

—

—

—

**Revenue Surprise**

**EPS Reported**

(0.33)

(0.55)

(0.83)

(2.22)

**EPS Estimate**

(0.33)

(0.68)

(0.38)

(0.22)

(0.08)

**EPS Surprise**

+0.00%

+19.12%

\-118.42%

\-909.09%

**Disclaimer**

Select reference data provided by FactSet. Copyright © 2026 FactSet Research Systems Inc.

### Related Stocks

- [GTBP.US](https://longbridge.com/en/quote/GTBP.US.md)
- [PBE.US](https://longbridge.com/en/quote/PBE.US.md)
- [XBI.US](https://longbridge.com/en/quote/XBI.US.md)
- [BIB.US](https://longbridge.com/en/quote/BIB.US.md)
- [FBT.US](https://longbridge.com/en/quote/FBT.US.md)
- [BBH.US](https://longbridge.com/en/quote/BBH.US.md)
- [SBIO.US](https://longbridge.com/en/quote/SBIO.US.md)
- [IBB.US](https://longbridge.com/en/quote/IBB.US.md)
- [IBBQ.US](https://longbridge.com/en/quote/IBBQ.US.md)
- [LABU.US](https://longbridge.com/en/quote/LABU.US.md)

## Related News & Research

- [GT Biopharma reports Q1 results](https://longbridge.com/en/news/286567387.md)
- [Precigen Q1 revenue beats estimates on PAPZIMEOS launch](https://longbridge.com/en/news/286311056.md)
- [Korro Bio To Advance KRRO-111 As Potential Treatment For AATD](https://longbridge.com/en/news/287089978.md)
- [BUZZ-Street View: Regeneron's melanoma trial setback raises bigger-picture questions](https://longbridge.com/en/news/286769076.md)
- [EXCLUSIVE: GT Biopharma Begins Testing Of Lead Solid Tumor Drug Candidate Across Multiple Cancer Types](https://longbridge.com/en/news/286415809.md)